Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin. Issue 5 (20th January 2022)

• Record Type: Journal Article
• Authors: Lindh, Claes; Samaratunga, Hemamali; Delahunt, Brett; Bergström, Rebecka; Chellappa, Venkatesh; Yaxley, John; Lindberg, Johan; Egevad, Lars
• Is Part Of: Prostate. Volume 82:Issue 5(2022)
• Page Start: 576
• Page End: 583
• Publication Date: 2022-01-20
• Subjects: clonality -- ductal adenocarcinoma -- genetics -- prostate cancer; Prostate -- Diseases -- Periodicals; 616
• DOI: 10.1002/pros.24304
• Languages: English
• ISSNs: 0270-4137

Abstract

Abstract: Background: Ductal adenocarcinoma (DA) is an aggressive subtype of prostate cancer. It is most commonly seen in mixed tumors together with conventional acinar adenocarcinoma (AA). The genetic profile of DA and its clonal origin is not fully characterized. Objective: To investigate whether DA represents a distinct genetic subtype and to investigate the somatic relationship between the ductal and acinar components of mixed cancers. Design, Setting, and Participants: In 17 radical prostatectomy specimens ductal and acinar tumor components from the same tumor foci were dissected. DNA was extracted and genomic sequencing performed. After exclusion of two cases with low cell yield, 15 paired samples remained for analysis. Results: In 12 of 15 cases a common somatic denominator was identified, while three cases had clonally separate components. In DA, TMPRSS2‐ERG gene fusions were detected in 47% (7/15), clonal FOXA1 alterations in 33% (5/15) and SPOP alterations in 27% (4/15) of cases. In one case KIAA1549−BRAF fusion was identified. Genome doubling events, resulting in an increased ploidy, were identified in the DA in 53% (8/15) of cases, but not seen in any AA. PTEN and CTNNB1 alterations were enriched in DA (6/15) but not seen in any AA. No cancers showed microsatellite instability or high tumor mutation burden. Conclusions: Ductal and acinar prostate adenocarcinoma components of mixed tumors most often share the same origin and are clonally related. DA components in mixed tumor often exhibit genome doubling events resulting in aneuploidy, consistent with the aggressive nature of high grade prostate cancer.